Medical Care
Global Biopharmaceutical CMO and CRO Market Research Report 2025
- Jun 28, 25
- ID: 346882
- Pages: 72
- Figures: 78
- Views: 2
The global market for Biopharmaceutical CMO and CRO was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Biopharmaceutical CMO and CRO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharmaceutical CMO and CRO.
The Biopharmaceutical CMO and CRO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biopharmaceutical CMO and CRO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biopharmaceutical CMO and CRO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AGC Biologics
Boehringer Ingelheim International GmbH
FUJIFILM Diosynth Biotechnologies
Inno Bio Ventures Sdn Bhd
JRS PHARMA
Lonza
PRA Health Sciences, Inc.
ProBioGen AG
Rentschler Biopharma SE
Samsung BioLogics
Segment by Type
Contract Manufacturing
Contract Research
Segment by Application
Biologics Manuefacturing
Biosimilars Manuefacturing
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biopharmaceutical CMO and CRO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Biopharmaceutical CMO and CRO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharmaceutical CMO and CRO.
The Biopharmaceutical CMO and CRO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biopharmaceutical CMO and CRO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biopharmaceutical CMO and CRO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AGC Biologics
Boehringer Ingelheim International GmbH
FUJIFILM Diosynth Biotechnologies
Inno Bio Ventures Sdn Bhd
JRS PHARMA
Lonza
PRA Health Sciences, Inc.
ProBioGen AG
Rentschler Biopharma SE
Samsung BioLogics
Segment by Type
Contract Manufacturing
Contract Research
Segment by Application
Biologics Manuefacturing
Biosimilars Manuefacturing
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biopharmaceutical CMO and CRO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biopharmaceutical CMO and CRO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Contract Manufacturing
1.2.3 Contract Research
1.3 Market by Application
1.3.1 Global Biopharmaceutical CMO and CRO Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biologics Manuefacturing
1.3.3 Biosimilars Manuefacturing
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biopharmaceutical CMO and CRO Market Perspective (2020-2031)
2.2 Global Biopharmaceutical CMO and CRO Growth Trends by Region
2.2.1 Global Biopharmaceutical CMO and CRO Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Biopharmaceutical CMO and CRO Historic Market Size by Region (2020-2025)
2.2.3 Biopharmaceutical CMO and CRO Forecasted Market Size by Region (2026-2031)
2.3 Biopharmaceutical CMO and CRO Market Dynamics
2.3.1 Biopharmaceutical CMO and CRO Industry Trends
2.3.2 Biopharmaceutical CMO and CRO Market Drivers
2.3.3 Biopharmaceutical CMO and CRO Market Challenges
2.3.4 Biopharmaceutical CMO and CRO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biopharmaceutical CMO and CRO Players by Revenue
3.1.1 Global Top Biopharmaceutical CMO and CRO Players by Revenue (2020-2025)
3.1.2 Global Biopharmaceutical CMO and CRO Revenue Market Share by Players (2020-2025)
3.2 Global Biopharmaceutical CMO and CRO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Biopharmaceutical CMO and CRO Revenue
3.4 Global Biopharmaceutical CMO and CRO Market Concentration Ratio
3.4.1 Global Biopharmaceutical CMO and CRO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical CMO and CRO Revenue in 2024
3.5 Global Key Players of Biopharmaceutical CMO and CRO Head office and Area Served
3.6 Global Key Players of Biopharmaceutical CMO and CRO, Product and Application
3.7 Global Key Players of Biopharmaceutical CMO and CRO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Biopharmaceutical CMO and CRO Breakdown Data by Type
4.1 Global Biopharmaceutical CMO and CRO Historic Market Size by Type (2020-2025)
4.2 Global Biopharmaceutical CMO and CRO Forecasted Market Size by Type (2026-2031)
5 Biopharmaceutical CMO and CRO Breakdown Data by Application
5.1 Global Biopharmaceutical CMO and CRO Historic Market Size by Application (2020-2025)
5.2 Global Biopharmaceutical CMO and CRO Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Biopharmaceutical CMO and CRO Market Size (2020-2031)
6.2 North America Biopharmaceutical CMO and CRO Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Biopharmaceutical CMO and CRO Market Size by Country (2020-2025)
6.4 North America Biopharmaceutical CMO and CRO Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biopharmaceutical CMO and CRO Market Size (2020-2031)
7.2 Europe Biopharmaceutical CMO and CRO Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Biopharmaceutical CMO and CRO Market Size by Country (2020-2025)
7.4 Europe Biopharmaceutical CMO and CRO Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biopharmaceutical CMO and CRO Market Size (2020-2031)
8.2 Asia-Pacific Biopharmaceutical CMO and CRO Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Biopharmaceutical CMO and CRO Market Size by Region (2020-2025)
8.4 Asia-Pacific Biopharmaceutical CMO and CRO Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biopharmaceutical CMO and CRO Market Size (2020-2031)
9.2 Latin America Biopharmaceutical CMO and CRO Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Biopharmaceutical CMO and CRO Market Size by Country (2020-2025)
9.4 Latin America Biopharmaceutical CMO and CRO Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biopharmaceutical CMO and CRO Market Size (2020-2031)
10.2 Middle East & Africa Biopharmaceutical CMO and CRO Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Country (2020-2025)
10.4 Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AGC Biologics
11.1.1 AGC Biologics Company Details
11.1.2 AGC Biologics Business Overview
11.1.3 AGC Biologics Biopharmaceutical CMO and CRO Introduction
11.1.4 AGC Biologics Revenue in Biopharmaceutical CMO and CRO Business (2020-2025)
11.1.5 AGC Biologics Recent Development
11.2 Boehringer Ingelheim International GmbH
11.2.1 Boehringer Ingelheim International GmbH Company Details
11.2.2 Boehringer Ingelheim International GmbH Business Overview
11.2.3 Boehringer Ingelheim International GmbH Biopharmaceutical CMO and CRO Introduction
11.2.4 Boehringer Ingelheim International GmbH Revenue in Biopharmaceutical CMO and CRO Business (2020-2025)
11.2.5 Boehringer Ingelheim International GmbH Recent Development
11.3 FUJIFILM Diosynth Biotechnologies
11.3.1 FUJIFILM Diosynth Biotechnologies Company Details
11.3.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.3.3 FUJIFILM Diosynth Biotechnologies Biopharmaceutical CMO and CRO Introduction
11.3.4 FUJIFILM Diosynth Biotechnologies Revenue in Biopharmaceutical CMO and CRO Business (2020-2025)
11.3.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.4 Inno Bio Ventures Sdn Bhd
11.4.1 Inno Bio Ventures Sdn Bhd Company Details
11.4.2 Inno Bio Ventures Sdn Bhd Business Overview
11.4.3 Inno Bio Ventures Sdn Bhd Biopharmaceutical CMO and CRO Introduction
11.4.4 Inno Bio Ventures Sdn Bhd Revenue in Biopharmaceutical CMO and CRO Business (2020-2025)
11.4.5 Inno Bio Ventures Sdn Bhd Recent Development
11.5 JRS PHARMA
11.5.1 JRS PHARMA Company Details
11.5.2 JRS PHARMA Business Overview
11.5.3 JRS PHARMA Biopharmaceutical CMO and CRO Introduction
11.5.4 JRS PHARMA Revenue in Biopharmaceutical CMO and CRO Business (2020-2025)
11.5.5 JRS PHARMA Recent Development
11.6 Lonza
11.6.1 Lonza Company Details
11.6.2 Lonza Business Overview
11.6.3 Lonza Biopharmaceutical CMO and CRO Introduction
11.6.4 Lonza Revenue in Biopharmaceutical CMO and CRO Business (2020-2025)
11.6.5 Lonza Recent Development
11.7 PRA Health Sciences, Inc.
11.7.1 PRA Health Sciences, Inc. Company Details
11.7.2 PRA Health Sciences, Inc. Business Overview
11.7.3 PRA Health Sciences, Inc. Biopharmaceutical CMO and CRO Introduction
11.7.4 PRA Health Sciences, Inc. Revenue in Biopharmaceutical CMO and CRO Business (2020-2025)
11.7.5 PRA Health Sciences, Inc. Recent Development
11.8 ProBioGen AG
11.8.1 ProBioGen AG Company Details
11.8.2 ProBioGen AG Business Overview
11.8.3 ProBioGen AG Biopharmaceutical CMO and CRO Introduction
11.8.4 ProBioGen AG Revenue in Biopharmaceutical CMO and CRO Business (2020-2025)
11.8.5 ProBioGen AG Recent Development
11.9 Rentschler Biopharma SE
11.9.1 Rentschler Biopharma SE Company Details
11.9.2 Rentschler Biopharma SE Business Overview
11.9.3 Rentschler Biopharma SE Biopharmaceutical CMO and CRO Introduction
11.9.4 Rentschler Biopharma SE Revenue in Biopharmaceutical CMO and CRO Business (2020-2025)
11.9.5 Rentschler Biopharma SE Recent Development
11.10 Samsung BioLogics
11.10.1 Samsung BioLogics Company Details
11.10.2 Samsung BioLogics Business Overview
11.10.3 Samsung BioLogics Biopharmaceutical CMO and CRO Introduction
11.10.4 Samsung BioLogics Revenue in Biopharmaceutical CMO and CRO Business (2020-2025)
11.10.5 Samsung BioLogics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biopharmaceutical CMO and CRO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Contract Manufacturing
1.2.3 Contract Research
1.3 Market by Application
1.3.1 Global Biopharmaceutical CMO and CRO Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biologics Manuefacturing
1.3.3 Biosimilars Manuefacturing
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biopharmaceutical CMO and CRO Market Perspective (2020-2031)
2.2 Global Biopharmaceutical CMO and CRO Growth Trends by Region
2.2.1 Global Biopharmaceutical CMO and CRO Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Biopharmaceutical CMO and CRO Historic Market Size by Region (2020-2025)
2.2.3 Biopharmaceutical CMO and CRO Forecasted Market Size by Region (2026-2031)
2.3 Biopharmaceutical CMO and CRO Market Dynamics
2.3.1 Biopharmaceutical CMO and CRO Industry Trends
2.3.2 Biopharmaceutical CMO and CRO Market Drivers
2.3.3 Biopharmaceutical CMO and CRO Market Challenges
2.3.4 Biopharmaceutical CMO and CRO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biopharmaceutical CMO and CRO Players by Revenue
3.1.1 Global Top Biopharmaceutical CMO and CRO Players by Revenue (2020-2025)
3.1.2 Global Biopharmaceutical CMO and CRO Revenue Market Share by Players (2020-2025)
3.2 Global Biopharmaceutical CMO and CRO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Biopharmaceutical CMO and CRO Revenue
3.4 Global Biopharmaceutical CMO and CRO Market Concentration Ratio
3.4.1 Global Biopharmaceutical CMO and CRO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical CMO and CRO Revenue in 2024
3.5 Global Key Players of Biopharmaceutical CMO and CRO Head office and Area Served
3.6 Global Key Players of Biopharmaceutical CMO and CRO, Product and Application
3.7 Global Key Players of Biopharmaceutical CMO and CRO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Biopharmaceutical CMO and CRO Breakdown Data by Type
4.1 Global Biopharmaceutical CMO and CRO Historic Market Size by Type (2020-2025)
4.2 Global Biopharmaceutical CMO and CRO Forecasted Market Size by Type (2026-2031)
5 Biopharmaceutical CMO and CRO Breakdown Data by Application
5.1 Global Biopharmaceutical CMO and CRO Historic Market Size by Application (2020-2025)
5.2 Global Biopharmaceutical CMO and CRO Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Biopharmaceutical CMO and CRO Market Size (2020-2031)
6.2 North America Biopharmaceutical CMO and CRO Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Biopharmaceutical CMO and CRO Market Size by Country (2020-2025)
6.4 North America Biopharmaceutical CMO and CRO Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biopharmaceutical CMO and CRO Market Size (2020-2031)
7.2 Europe Biopharmaceutical CMO and CRO Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Biopharmaceutical CMO and CRO Market Size by Country (2020-2025)
7.4 Europe Biopharmaceutical CMO and CRO Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biopharmaceutical CMO and CRO Market Size (2020-2031)
8.2 Asia-Pacific Biopharmaceutical CMO and CRO Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Biopharmaceutical CMO and CRO Market Size by Region (2020-2025)
8.4 Asia-Pacific Biopharmaceutical CMO and CRO Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biopharmaceutical CMO and CRO Market Size (2020-2031)
9.2 Latin America Biopharmaceutical CMO and CRO Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Biopharmaceutical CMO and CRO Market Size by Country (2020-2025)
9.4 Latin America Biopharmaceutical CMO and CRO Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biopharmaceutical CMO and CRO Market Size (2020-2031)
10.2 Middle East & Africa Biopharmaceutical CMO and CRO Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Country (2020-2025)
10.4 Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AGC Biologics
11.1.1 AGC Biologics Company Details
11.1.2 AGC Biologics Business Overview
11.1.3 AGC Biologics Biopharmaceutical CMO and CRO Introduction
11.1.4 AGC Biologics Revenue in Biopharmaceutical CMO and CRO Business (2020-2025)
11.1.5 AGC Biologics Recent Development
11.2 Boehringer Ingelheim International GmbH
11.2.1 Boehringer Ingelheim International GmbH Company Details
11.2.2 Boehringer Ingelheim International GmbH Business Overview
11.2.3 Boehringer Ingelheim International GmbH Biopharmaceutical CMO and CRO Introduction
11.2.4 Boehringer Ingelheim International GmbH Revenue in Biopharmaceutical CMO and CRO Business (2020-2025)
11.2.5 Boehringer Ingelheim International GmbH Recent Development
11.3 FUJIFILM Diosynth Biotechnologies
11.3.1 FUJIFILM Diosynth Biotechnologies Company Details
11.3.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.3.3 FUJIFILM Diosynth Biotechnologies Biopharmaceutical CMO and CRO Introduction
11.3.4 FUJIFILM Diosynth Biotechnologies Revenue in Biopharmaceutical CMO and CRO Business (2020-2025)
11.3.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.4 Inno Bio Ventures Sdn Bhd
11.4.1 Inno Bio Ventures Sdn Bhd Company Details
11.4.2 Inno Bio Ventures Sdn Bhd Business Overview
11.4.3 Inno Bio Ventures Sdn Bhd Biopharmaceutical CMO and CRO Introduction
11.4.4 Inno Bio Ventures Sdn Bhd Revenue in Biopharmaceutical CMO and CRO Business (2020-2025)
11.4.5 Inno Bio Ventures Sdn Bhd Recent Development
11.5 JRS PHARMA
11.5.1 JRS PHARMA Company Details
11.5.2 JRS PHARMA Business Overview
11.5.3 JRS PHARMA Biopharmaceutical CMO and CRO Introduction
11.5.4 JRS PHARMA Revenue in Biopharmaceutical CMO and CRO Business (2020-2025)
11.5.5 JRS PHARMA Recent Development
11.6 Lonza
11.6.1 Lonza Company Details
11.6.2 Lonza Business Overview
11.6.3 Lonza Biopharmaceutical CMO and CRO Introduction
11.6.4 Lonza Revenue in Biopharmaceutical CMO and CRO Business (2020-2025)
11.6.5 Lonza Recent Development
11.7 PRA Health Sciences, Inc.
11.7.1 PRA Health Sciences, Inc. Company Details
11.7.2 PRA Health Sciences, Inc. Business Overview
11.7.3 PRA Health Sciences, Inc. Biopharmaceutical CMO and CRO Introduction
11.7.4 PRA Health Sciences, Inc. Revenue in Biopharmaceutical CMO and CRO Business (2020-2025)
11.7.5 PRA Health Sciences, Inc. Recent Development
11.8 ProBioGen AG
11.8.1 ProBioGen AG Company Details
11.8.2 ProBioGen AG Business Overview
11.8.3 ProBioGen AG Biopharmaceutical CMO and CRO Introduction
11.8.4 ProBioGen AG Revenue in Biopharmaceutical CMO and CRO Business (2020-2025)
11.8.5 ProBioGen AG Recent Development
11.9 Rentschler Biopharma SE
11.9.1 Rentschler Biopharma SE Company Details
11.9.2 Rentschler Biopharma SE Business Overview
11.9.3 Rentschler Biopharma SE Biopharmaceutical CMO and CRO Introduction
11.9.4 Rentschler Biopharma SE Revenue in Biopharmaceutical CMO and CRO Business (2020-2025)
11.9.5 Rentschler Biopharma SE Recent Development
11.10 Samsung BioLogics
11.10.1 Samsung BioLogics Company Details
11.10.2 Samsung BioLogics Business Overview
11.10.3 Samsung BioLogics Biopharmaceutical CMO and CRO Introduction
11.10.4 Samsung BioLogics Revenue in Biopharmaceutical CMO and CRO Business (2020-2025)
11.10.5 Samsung BioLogics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Biopharmaceutical CMO and CRO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Contract Manufacturing
Table 3. Key Players of Contract Research
Table 4. Global Biopharmaceutical CMO and CRO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Biopharmaceutical CMO and CRO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Biopharmaceutical CMO and CRO Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Biopharmaceutical CMO and CRO Market Share by Region (2020-2025)
Table 8. Global Biopharmaceutical CMO and CRO Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Biopharmaceutical CMO and CRO Market Share by Region (2026-2031)
Table 10. Biopharmaceutical CMO and CRO Market Trends
Table 11. Biopharmaceutical CMO and CRO Market Drivers
Table 12. Biopharmaceutical CMO and CRO Market Challenges
Table 13. Biopharmaceutical CMO and CRO Market Restraints
Table 14. Global Biopharmaceutical CMO and CRO Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Biopharmaceutical CMO and CRO Market Share by Players (2020-2025)
Table 16. Global Top Biopharmaceutical CMO and CRO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical CMO and CRO as of 2024)
Table 17. Ranking of Global Top Biopharmaceutical CMO and CRO Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Biopharmaceutical CMO and CRO Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Biopharmaceutical CMO and CRO, Headquarters and Area Served
Table 20. Global Key Players of Biopharmaceutical CMO and CRO, Product and Application
Table 21. Global Key Players of Biopharmaceutical CMO and CRO, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Biopharmaceutical CMO and CRO Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Biopharmaceutical CMO and CRO Revenue Market Share by Type (2020-2025)
Table 25. Global Biopharmaceutical CMO and CRO Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Biopharmaceutical CMO and CRO Revenue Market Share by Type (2026-2031)
Table 27. Global Biopharmaceutical CMO and CRO Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Biopharmaceutical CMO and CRO Revenue Market Share by Application (2020-2025)
Table 29. Global Biopharmaceutical CMO and CRO Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Biopharmaceutical CMO and CRO Revenue Market Share by Application (2026-2031)
Table 31. North America Biopharmaceutical CMO and CRO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Biopharmaceutical CMO and CRO Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Biopharmaceutical CMO and CRO Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Biopharmaceutical CMO and CRO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Biopharmaceutical CMO and CRO Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Biopharmaceutical CMO and CRO Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Biopharmaceutical CMO and CRO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Biopharmaceutical CMO and CRO Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Biopharmaceutical CMO and CRO Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Biopharmaceutical CMO and CRO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Biopharmaceutical CMO and CRO Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Biopharmaceutical CMO and CRO Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Biopharmaceutical CMO and CRO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Country (2026-2031) & (US$ Million)
Table 46. AGC Biologics Company Details
Table 47. AGC Biologics Business Overview
Table 48. AGC Biologics Biopharmaceutical CMO and CRO Product
Table 49. AGC Biologics Revenue in Biopharmaceutical CMO and CRO Business (2020-2025) & (US$ Million)
Table 50. AGC Biologics Recent Development
Table 51. Boehringer Ingelheim International GmbH Company Details
Table 52. Boehringer Ingelheim International GmbH Business Overview
Table 53. Boehringer Ingelheim International GmbH Biopharmaceutical CMO and CRO Product
Table 54. Boehringer Ingelheim International GmbH Revenue in Biopharmaceutical CMO and CRO Business (2020-2025) & (US$ Million)
Table 55. Boehringer Ingelheim International GmbH Recent Development
Table 56. FUJIFILM Diosynth Biotechnologies Company Details
Table 57. FUJIFILM Diosynth Biotechnologies Business Overview
Table 58. FUJIFILM Diosynth Biotechnologies Biopharmaceutical CMO and CRO Product
Table 59. FUJIFILM Diosynth Biotechnologies Revenue in Biopharmaceutical CMO and CRO Business (2020-2025) & (US$ Million)
Table 60. FUJIFILM Diosynth Biotechnologies Recent Development
Table 61. Inno Bio Ventures Sdn Bhd Company Details
Table 62. Inno Bio Ventures Sdn Bhd Business Overview
Table 63. Inno Bio Ventures Sdn Bhd Biopharmaceutical CMO and CRO Product
Table 64. Inno Bio Ventures Sdn Bhd Revenue in Biopharmaceutical CMO and CRO Business (2020-2025) & (US$ Million)
Table 65. Inno Bio Ventures Sdn Bhd Recent Development
Table 66. JRS PHARMA Company Details
Table 67. JRS PHARMA Business Overview
Table 68. JRS PHARMA Biopharmaceutical CMO and CRO Product
Table 69. JRS PHARMA Revenue in Biopharmaceutical CMO and CRO Business (2020-2025) & (US$ Million)
Table 70. JRS PHARMA Recent Development
Table 71. Lonza Company Details
Table 72. Lonza Business Overview
Table 73. Lonza Biopharmaceutical CMO and CRO Product
Table 74. Lonza Revenue in Biopharmaceutical CMO and CRO Business (2020-2025) & (US$ Million)
Table 75. Lonza Recent Development
Table 76. PRA Health Sciences, Inc. Company Details
Table 77. PRA Health Sciences, Inc. Business Overview
Table 78. PRA Health Sciences, Inc. Biopharmaceutical CMO and CRO Product
Table 79. PRA Health Sciences, Inc. Revenue in Biopharmaceutical CMO and CRO Business (2020-2025) & (US$ Million)
Table 80. PRA Health Sciences, Inc. Recent Development
Table 81. ProBioGen AG Company Details
Table 82. ProBioGen AG Business Overview
Table 83. ProBioGen AG Biopharmaceutical CMO and CRO Product
Table 84. ProBioGen AG Revenue in Biopharmaceutical CMO and CRO Business (2020-2025) & (US$ Million)
Table 85. ProBioGen AG Recent Development
Table 86. Rentschler Biopharma SE Company Details
Table 87. Rentschler Biopharma SE Business Overview
Table 88. Rentschler Biopharma SE Biopharmaceutical CMO and CRO Product
Table 89. Rentschler Biopharma SE Revenue in Biopharmaceutical CMO and CRO Business (2020-2025) & (US$ Million)
Table 90. Rentschler Biopharma SE Recent Development
Table 91. Samsung BioLogics Company Details
Table 92. Samsung BioLogics Business Overview
Table 93. Samsung BioLogics Biopharmaceutical CMO and CRO Product
Table 94. Samsung BioLogics Revenue in Biopharmaceutical CMO and CRO Business (2020-2025) & (US$ Million)
Table 95. Samsung BioLogics Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
Table 99. Authors List of This Report
List of Figures
Figure 1. Biopharmaceutical CMO and CRO Picture
Figure 2. Global Biopharmaceutical CMO and CRO Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Biopharmaceutical CMO and CRO Market Share by Type: 2024 VS 2031
Figure 4. Contract Manufacturing Features
Figure 5. Contract Research Features
Figure 6. Global Biopharmaceutical CMO and CRO Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Biopharmaceutical CMO and CRO Market Share by Application: 2024 VS 2031
Figure 8. Biologics Manuefacturing Case Studies
Figure 9. Biosimilars Manuefacturing Case Studies
Figure 10. Other Case Studies
Figure 11. Biopharmaceutical CMO and CRO Report Years Considered
Figure 12. Global Biopharmaceutical CMO and CRO Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Biopharmaceutical CMO and CRO Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Biopharmaceutical CMO and CRO Market Share by Region: 2024 VS 2031
Figure 15. Global Biopharmaceutical CMO and CRO Market Share by Players in 2024
Figure 16. Global Top Biopharmaceutical CMO and CRO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical CMO and CRO as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Biopharmaceutical CMO and CRO Revenue in 2024
Figure 18. North America Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Biopharmaceutical CMO and CRO Market Share by Country (2020-2031)
Figure 20. United States Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Biopharmaceutical CMO and CRO Market Share by Country (2020-2031)
Figure 24. Germany Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Biopharmaceutical CMO and CRO Market Share by Region (2020-2031)
Figure 32. China Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Biopharmaceutical CMO and CRO Market Share by Country (2020-2031)
Figure 40. Mexico Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Biopharmaceutical CMO and CRO Market Share by Country (2020-2031)
Figure 44. Turkey Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. AGC Biologics Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2020-2025)
Figure 48. Boehringer Ingelheim International GmbH Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2020-2025)
Figure 49. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2020-2025)
Figure 50. Inno Bio Ventures Sdn Bhd Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2020-2025)
Figure 51. JRS PHARMA Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2020-2025)
Figure 52. Lonza Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2020-2025)
Figure 53. PRA Health Sciences, Inc. Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2020-2025)
Figure 54. ProBioGen AG Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2020-2025)
Figure 55. Rentschler Biopharma SE Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2020-2025)
Figure 56. Samsung BioLogics Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2020-2025)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Table 1. Global Biopharmaceutical CMO and CRO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Contract Manufacturing
Table 3. Key Players of Contract Research
Table 4. Global Biopharmaceutical CMO and CRO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Biopharmaceutical CMO and CRO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Biopharmaceutical CMO and CRO Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Biopharmaceutical CMO and CRO Market Share by Region (2020-2025)
Table 8. Global Biopharmaceutical CMO and CRO Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Biopharmaceutical CMO and CRO Market Share by Region (2026-2031)
Table 10. Biopharmaceutical CMO and CRO Market Trends
Table 11. Biopharmaceutical CMO and CRO Market Drivers
Table 12. Biopharmaceutical CMO and CRO Market Challenges
Table 13. Biopharmaceutical CMO and CRO Market Restraints
Table 14. Global Biopharmaceutical CMO and CRO Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Biopharmaceutical CMO and CRO Market Share by Players (2020-2025)
Table 16. Global Top Biopharmaceutical CMO and CRO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical CMO and CRO as of 2024)
Table 17. Ranking of Global Top Biopharmaceutical CMO and CRO Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Biopharmaceutical CMO and CRO Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Biopharmaceutical CMO and CRO, Headquarters and Area Served
Table 20. Global Key Players of Biopharmaceutical CMO and CRO, Product and Application
Table 21. Global Key Players of Biopharmaceutical CMO and CRO, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Biopharmaceutical CMO and CRO Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Biopharmaceutical CMO and CRO Revenue Market Share by Type (2020-2025)
Table 25. Global Biopharmaceutical CMO and CRO Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Biopharmaceutical CMO and CRO Revenue Market Share by Type (2026-2031)
Table 27. Global Biopharmaceutical CMO and CRO Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Biopharmaceutical CMO and CRO Revenue Market Share by Application (2020-2025)
Table 29. Global Biopharmaceutical CMO and CRO Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Biopharmaceutical CMO and CRO Revenue Market Share by Application (2026-2031)
Table 31. North America Biopharmaceutical CMO and CRO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Biopharmaceutical CMO and CRO Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Biopharmaceutical CMO and CRO Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Biopharmaceutical CMO and CRO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Biopharmaceutical CMO and CRO Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Biopharmaceutical CMO and CRO Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Biopharmaceutical CMO and CRO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Biopharmaceutical CMO and CRO Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Biopharmaceutical CMO and CRO Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Biopharmaceutical CMO and CRO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Biopharmaceutical CMO and CRO Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Biopharmaceutical CMO and CRO Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Biopharmaceutical CMO and CRO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Biopharmaceutical CMO and CRO Market Size by Country (2026-2031) & (US$ Million)
Table 46. AGC Biologics Company Details
Table 47. AGC Biologics Business Overview
Table 48. AGC Biologics Biopharmaceutical CMO and CRO Product
Table 49. AGC Biologics Revenue in Biopharmaceutical CMO and CRO Business (2020-2025) & (US$ Million)
Table 50. AGC Biologics Recent Development
Table 51. Boehringer Ingelheim International GmbH Company Details
Table 52. Boehringer Ingelheim International GmbH Business Overview
Table 53. Boehringer Ingelheim International GmbH Biopharmaceutical CMO and CRO Product
Table 54. Boehringer Ingelheim International GmbH Revenue in Biopharmaceutical CMO and CRO Business (2020-2025) & (US$ Million)
Table 55. Boehringer Ingelheim International GmbH Recent Development
Table 56. FUJIFILM Diosynth Biotechnologies Company Details
Table 57. FUJIFILM Diosynth Biotechnologies Business Overview
Table 58. FUJIFILM Diosynth Biotechnologies Biopharmaceutical CMO and CRO Product
Table 59. FUJIFILM Diosynth Biotechnologies Revenue in Biopharmaceutical CMO and CRO Business (2020-2025) & (US$ Million)
Table 60. FUJIFILM Diosynth Biotechnologies Recent Development
Table 61. Inno Bio Ventures Sdn Bhd Company Details
Table 62. Inno Bio Ventures Sdn Bhd Business Overview
Table 63. Inno Bio Ventures Sdn Bhd Biopharmaceutical CMO and CRO Product
Table 64. Inno Bio Ventures Sdn Bhd Revenue in Biopharmaceutical CMO and CRO Business (2020-2025) & (US$ Million)
Table 65. Inno Bio Ventures Sdn Bhd Recent Development
Table 66. JRS PHARMA Company Details
Table 67. JRS PHARMA Business Overview
Table 68. JRS PHARMA Biopharmaceutical CMO and CRO Product
Table 69. JRS PHARMA Revenue in Biopharmaceutical CMO and CRO Business (2020-2025) & (US$ Million)
Table 70. JRS PHARMA Recent Development
Table 71. Lonza Company Details
Table 72. Lonza Business Overview
Table 73. Lonza Biopharmaceutical CMO and CRO Product
Table 74. Lonza Revenue in Biopharmaceutical CMO and CRO Business (2020-2025) & (US$ Million)
Table 75. Lonza Recent Development
Table 76. PRA Health Sciences, Inc. Company Details
Table 77. PRA Health Sciences, Inc. Business Overview
Table 78. PRA Health Sciences, Inc. Biopharmaceutical CMO and CRO Product
Table 79. PRA Health Sciences, Inc. Revenue in Biopharmaceutical CMO and CRO Business (2020-2025) & (US$ Million)
Table 80. PRA Health Sciences, Inc. Recent Development
Table 81. ProBioGen AG Company Details
Table 82. ProBioGen AG Business Overview
Table 83. ProBioGen AG Biopharmaceutical CMO and CRO Product
Table 84. ProBioGen AG Revenue in Biopharmaceutical CMO and CRO Business (2020-2025) & (US$ Million)
Table 85. ProBioGen AG Recent Development
Table 86. Rentschler Biopharma SE Company Details
Table 87. Rentschler Biopharma SE Business Overview
Table 88. Rentschler Biopharma SE Biopharmaceutical CMO and CRO Product
Table 89. Rentschler Biopharma SE Revenue in Biopharmaceutical CMO and CRO Business (2020-2025) & (US$ Million)
Table 90. Rentschler Biopharma SE Recent Development
Table 91. Samsung BioLogics Company Details
Table 92. Samsung BioLogics Business Overview
Table 93. Samsung BioLogics Biopharmaceutical CMO and CRO Product
Table 94. Samsung BioLogics Revenue in Biopharmaceutical CMO and CRO Business (2020-2025) & (US$ Million)
Table 95. Samsung BioLogics Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
Table 99. Authors List of This Report
List of Figures
Figure 1. Biopharmaceutical CMO and CRO Picture
Figure 2. Global Biopharmaceutical CMO and CRO Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Biopharmaceutical CMO and CRO Market Share by Type: 2024 VS 2031
Figure 4. Contract Manufacturing Features
Figure 5. Contract Research Features
Figure 6. Global Biopharmaceutical CMO and CRO Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Biopharmaceutical CMO and CRO Market Share by Application: 2024 VS 2031
Figure 8. Biologics Manuefacturing Case Studies
Figure 9. Biosimilars Manuefacturing Case Studies
Figure 10. Other Case Studies
Figure 11. Biopharmaceutical CMO and CRO Report Years Considered
Figure 12. Global Biopharmaceutical CMO and CRO Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Biopharmaceutical CMO and CRO Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Biopharmaceutical CMO and CRO Market Share by Region: 2024 VS 2031
Figure 15. Global Biopharmaceutical CMO and CRO Market Share by Players in 2024
Figure 16. Global Top Biopharmaceutical CMO and CRO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical CMO and CRO as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Biopharmaceutical CMO and CRO Revenue in 2024
Figure 18. North America Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Biopharmaceutical CMO and CRO Market Share by Country (2020-2031)
Figure 20. United States Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Biopharmaceutical CMO and CRO Market Share by Country (2020-2031)
Figure 24. Germany Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Biopharmaceutical CMO and CRO Market Share by Region (2020-2031)
Figure 32. China Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Biopharmaceutical CMO and CRO Market Share by Country (2020-2031)
Figure 40. Mexico Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Biopharmaceutical CMO and CRO Market Share by Country (2020-2031)
Figure 44. Turkey Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Biopharmaceutical CMO and CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. AGC Biologics Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2020-2025)
Figure 48. Boehringer Ingelheim International GmbH Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2020-2025)
Figure 49. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2020-2025)
Figure 50. Inno Bio Ventures Sdn Bhd Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2020-2025)
Figure 51. JRS PHARMA Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2020-2025)
Figure 52. Lonza Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2020-2025)
Figure 53. PRA Health Sciences, Inc. Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2020-2025)
Figure 54. ProBioGen AG Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2020-2025)
Figure 55. Rentschler Biopharma SE Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2020-2025)
Figure 56. Samsung BioLogics Revenue Growth Rate in Biopharmaceutical CMO and CRO Business (2020-2025)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232